Author(s): Rishikesh S. Bachhav, Khanderao R. Jadhav, Prashan S.Malpure, Poonam R. Shinde


DOI: 10.52711/0974-360X.2023.00722   

Address: Rishikesh S. Bachhav*, Khanderao R. Jadhav, Prashan S.Malpure, Poonam R. Shinde
Kalyani Charitable Trust’s R.G.Sapkal College of Pharmacy, Anjaneri, Trimbakeshwar, Nashik, Maharashtra, India 422 213.
*Corresponding Author

Published In:   Volume - 16,      Issue - 9,     Year - 2023

To study the effect of Hemidesmus indicus fraction (HIF) on diabetic neuropathy elicited by Streptozotocin (STZ) using dried root powder of Hemidesmus indicus (HI).HI root powder was subjected to soxhlet extraction successively with petroleum ether (60-80°C for 72 hr) in a soxhlet apparatus. The preliminary phytochemical analysis of the HI root extract indicated the presence of steroids, terpenoid, coumarins, and flavonoids. The HI extract was subjected to column chromatography by using 250 g of Silica Gel G, successively eluted with a mobile phase of with a petroleum ether., petroleum ether-benzene(4:1), benzene and benzene-ethyl acetate mixture (1:1) was carried out. The fraction of HI (HIF) were collected and subjected to a chemical test, developed red–violet colour indicating the presence of terpenoid like lupeol, further on TLC of 0.1% HIF and standard lupeol in methanol showed development of violet colour with Rf value of 0.45 compared with standard lupeol. Acute toxicity was carried out as per OECD guidelines no. 423. Wistar albino adult rats of either sex weighing 180–200 g and 10–12 weeks old fasted overnight, and a single intraperitoneal injection of 65 mg/kg streptozotocin was used to induce diabetic neuropathy. The thirty-six Wistar albino rats were divided into six groups and subjected to thermal hyperalgesia and cold allodynia evaluations using tail immersion and the hot plate method. The inhibition of aldose reductase in-vitro was carried out. The HIF did not exhibit any toxicity when given orally at a dose of 2000 mg/kg b.w., and the experimental group neither shows marked behavioral changes nor mortality. In contrast to Normal Conrol (NC), and the Diabetic Control (DC) group demonstrated a reduction in reaction time (hyperalgesia), but HIF at various dosages (HIF50, HIF100, and HIF200) and SCG were associated with a considerable prolongation of reaction time. At different dosage levels, HIF significantly decreased blood sugar levels (BSL) and body weight on 15thd and 28th d in STZ induced diabetic rats. Aldose reductase inhibition in vitro was noted with an IC50 of 126.09µg/mL.The study demonstrate lupeol containing HIF inhibits hyperalgesia and lowers BSL in experimental diabetic neuropathy. Aldose-reductase (AR) levels were also decreased, which may be a significant factor in lowering the risk of diabetic neuropathy complications.

Cite this article:
Rishikesh S. Bachhav, Khanderao R. Jadhav, Prashan S.Malpure, Poonam R. Shinde. Hemidesmus indicus R. Br. Fraction Ameliorates Diabetic Neuropathy Caused by Streptozotocin. Research Journal of Pharmacy and Technology 2023; 16(9):4423-0. doi: 10.52711/0974-360X.2023.00722

Rishikesh S. Bachhav, Khanderao R. Jadhav, Prashan S.Malpure, Poonam R. Shinde. Hemidesmus indicus R. Br. Fraction Ameliorates Diabetic Neuropathy Caused by Streptozotocin. Research Journal of Pharmacy and Technology 2023; 16(9):4423-0. doi: 10.52711/0974-360X.2023.00722   Available on:

1.    Edwin E, Sheeja E, Dhanabal S, Suresh B. Antihyperglycemic activity of Passiflora mollissima bailey. Indian Journal of Pharmaceutical Sciences. 2007;69(4):570-.71. doi: 10.4103/0250-474X.36947.
2.    Kamenov ZA, Parapunova RA, Georgieva RT. Earlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus. Gender medicine. 2010;7(6):600-15.doi: 10.1016/j.genm.2010.11.001, PMID 21195360.
3.    Inukai T, Fujiwara Y, Tayama K, Aso Y, Takemura Y. Serum levels of carboxy-terminal propeptide of human type I procollagen are an indicator for the progression of diabetic nephropathy in patients with Type 2 diabetes mellitus. Diabetes research and clinical practice. 2000;48(1):23-8. doi:10.1016/s0168-8227(99)00137-0, PMID 10704696.
4.    Chait A, Bornfeldt KE. Diabetes and atherosclerosis: is there a role for hyperglycemia?. Journal of lipid research. 2009 ;50:S335-9.doi: 10.1194/jlr.R800059-JLR200, PMID 19029122.
5.    Romero-Aroca P, Fernández-Balart J, Baget-Bernaldiz M, Martinez-Salcedo I, Méndez-Marín I, Salvat-Serra M, Buil-Calvo JA. Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients. Journal of diabetes and its complications. 2009;23(4):229-38. doi: 10.1016/j.jdiacomp.2008.02.012, PMID 18439844.
6.    Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'brien PC, Melton L. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817-.doi:10.1212/wnl.43.4.817, PMID8469345.
7.    Yadav SK, Nagori BP, Desai PK. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy. Journal of ethnopharmacology. 2014;152(2):349-57.doi:10.1016/j.jep.2014.01.020, PMID 24486599.
8.    Boulton AJ, Ward JD. Diabetic neuropathies and pain. Clinics in endocrinology and metabolism. 1986;15(4):917-31.doi: 10.1016/S0300-595X(86)80080-9
9.    Anonymous.The Useful Plants of India (New Delhi: Council of Industrial and Scientific Research, 1986).
10.    Anonymous. The Wealth of India (Raw Material),Vol III (New Delhi: Council of Industrial and Scientific Research, 1997)
11.    Nadkarni AN. Indian Materia Medica. Vol I (Popular Book Depot, Bombay, India 1989).
12.    Mukherjee B. The Indian Pharmaceutical Codex. Vol II (Indigenous drugs), (New Delhi, India: Council of Industrial and Scientific Research, , India 1953).
13.    Chopra RN, Nayar SL and Chopra IC. Glossary of Indian Medicinal Plants.( New Delhi, India: Council of Industrial and Scientific Research, 1956).
14.    Kirtikar KR, Basu BD. Indian Medicinal Plants.Vol I-IV, (Bishen Singh Mahendra Pal Singh, Deharadun 1980).
15.    Kirtikar KR, Basu BD.. Vol I, (International Book Publisher, Deharadun, 1993) Indian Med Plants I: 641.
16.    Gupta R, Sharma AK, Sharma MC, Dobhal MP, Gupta RS. Evaluation of antidiabetic and antioxidant potential of lupeol in experimental hyperglycaemia. Natural Product Research. 2012; 26(12): 1125-9.doi: 10.1080/14786419.2011.560845, PMID 22043924.
17.    Verma PR, Joharapurkar AA, Chatpalliwar VA, Asnani AJ. Antinociceptive activity of alcoholic extract of Hemidesmus indicus R. Br. in mice. Journal of Ethnopharmacology. 2005; 102(2):298-301.doi: 10.1016/j.jep.2005.05.039, PMID 16081231.
18.    Jain SP, Singh SC. Ethno-Medico-Botanicals Survey of Ambikapur District, MP. (Fourth International Congress of Ethnobiology, NBRI:Lucknow, U. P. India 1994).
19.    Murti P, Seshadri TR. A study of the chemical components of the roots of Decalepis Hamiltonii (Makali Veru). InProceedings of the Indian Academy of Sciences-Section A. 1941; 13(3): 221-232. Springer India.
20.    Padhy SN. Triterpenoids from the roots of Hemidesmus indicus. Phytochemistry. 1973; 12: 217-8. doi: 10.1016/S0031-9422(00)84656-7.
21.    Tirumani P, Venu S, Sridhar G, Praveen Kumar M, Rajashekhar AV, Naga Raju T. Delaying of cataract through intervention of Hemidesmus indicus in STZ induced diabetic rats. Natural Product Research. 2018 ;32(11): 1295-8. doi: 10.1080/14786419.2017.1333991, PMID 28580798.
22.    Pushpanjali G, Vishnupriya V, Ponnulakshmi R, Gayathri R, Madhan K, Shyamaladevi B, Selvaraj J. Effect of lupeol on enzymatic and non-enzymatic antioxidants in type-2 diabetic adult male Wistar rats. Drug Invention Today. 2019 ;12(5).
23.    Nandy S, Mukherjee A, Pandey DK, Ray P, Dey A. Indian Sarsaparilla (Hemidesmus indicus): Recent progress in research on ethnobotany, phytochemistry and pharmacology. Journal of Ethnopharmacology. 2020;254:112609.doi: 10.1016/j.jep.2020.112609, PMID 32007632.
24.    Singh S, Dhande SR, Aggarwal SM, Suryawanshi A, Kadam V. In vitro Antioxidant Activity of 70% Methanolic Extracts of Roots of Hemidesmus indicus. Research Journal of Pharmacy and Technology. 2012 ;5(9):1241-5
25.    Katekhaye S , Laddha K & Ferreira, Galvina & Mulik, Mandar and Agrawal, Poonam and Akhade, Meenakshi. 2019. Extraction and Isolation of Phytochemicals: A Practical Approach.
26.    Khandelwal KR. Practical Pharmacognosy Techniques and Experiments. 19th ed. Nirali Prakashan Pune; 2007. p. 149-56.
27.    Harbone JB. Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. 5th ed. London. Chapman and Hill; 2007. p. 279-83.
28.    Wagner H, Bladt S, Zgainski EM. TLC screening of an unknown commercial drug. Germany: Springer -Verlag; 2001. p. 291-305
29.    Schlede E. Oral Acute Toxic Class Method: OECD Test Guideline 423. Rapporti Istisan. Vol.41. 2002:32-6.
30.    Frank B. Dose L. Streptozotocin Induction Protocol (Mouse). Animal Models of Diabetic Complication Consortium.
31.    Nadig PD, Revankar RR, Dethe SM, Narayanswamy SB, Aliyar MA. Effect of Tinospora cordifolia on experimental diabetic neuropathy. Indian Journal of Pharmacology. 2012 ;44(5):580.doi: 10.4103/0253-7613.100380, PMID 23112417.
32.    Anjaneyulu M, Chopra K. Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. Indian Journal of Experimental Biology. 2004; 42:766-69. PMID 15573524.
33.    Morani AS, Bodhankar SL. Neuroprotective effect of early treatment with pioglitasone and vitamin E acetate in alloxan induced diabetes in rats. Pharmacologyonline. 2007;3:308-22.
34.    Adhikteari R, JyothiY,BoraD,Vamsee VA. Combined effect of aqueous extract of Curcuma longa Linn. With metformin in diabetes induced neuropathic pain in rats. Asian Journal of Pharmaceutical and Clinical Research. 2015;8:166-70.
35.    Hayman S, Kinoshita JH. Isolation and properties of lens aldose reductase. Journal of Biological Chemistry. 1965; 240(2):877-82.doi: 10.1016/S0021-9258(17) 45256-2, PMID 14275148.
36.    Gul H, Yildiz O, Dogrul A, Yesilyurt O, Isimer A. The interaction between IL-1β and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain. 2000;89(1):39-45.doi: 10.1016/S0304-3959(00)00343-2, PMID 11113291.
37.    Calcutt NA, Chaplan SR. Spinal pharmacology of tactile allodynia in diabetic rats. British journal of pharmacology. 1997; 122(7): 1478. doi: 10.1038/sj.bjp.0701538, PMID 9421298.
38.    Pop‐Busui R, Sima A, Stevens M. Diabetic neuropathy and oxidative stress. Diabetes/metabolism research and reviews. 2006; 22(4): 257-73.doi: 10.1002/dmrr.625, PMID 16506271.
39.    Hoybergs YM, Biermans RL, Meert TF. The impact of bodyweight and body condition on behavioral testing for painful diabetic neuropathy in the streptozotocin rat model. Neuroscience letters. 2008;436(1): 13-8.doi: 10.1016/j.neulet.2008.02.051, PMID 18375060.
40.    Ilnytska O, Lyzogubov VV, Stevens MJ, Drel VR, Mashtalir N, Pacher P, Yorek MA, Obrosova IG. Poly (ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes. 2006;55(6):1686-94.doi: 10.2337/db06-0067, PMID 16731831.
41.    Serra J, Solà R, Quiles C, Casanova-Molla J, Pascual V, Bostock H, Valls-Solé J. C-nociceptors sensitized to cold in a patient with small-fiber neuropathy and cold allodynia. Pain. 2009;147(1-3):46-53.
42.    Fruhstorfer H. Thermal sensibility changes during ischemie nerve block. Pain. 1984;20(4):355-61.doi: 10.1016/0304-3959(84)90112-X, PMID 6522070.
43.    Yarnitsky D, Ochoa JL. Release of cold-induced burning pain by block of cold-specific afferent input. Brain. 1990;113(4):893-902.doi: 10.1093/brain/113.4.893, PMID 2397391.
44.    Ochoa JL, Yarnitsky D. The triple cold syndrome: cold hyperalgesia, cold hypoaesthesia and cold skin in peripheral nerve disease. Brain. 1994;117(1):185-97. doi: 10.1093/brain/117.1.185, PMID 8149211.
45.    Campero M, Baumann TK, Bostock H, Ochoa JL. Human cutaneous C fibres activated by cooling, heating and menthol. The Journal of Physiology. 2009; 587(23): 5633-52.doi: 10.1113/jphysiol.2009.176040, PMID 19822550.
46.    Darekar RS, Khetre AB, Sinha PK, Jeswani RM, Damle MC. quantitation of lupeol octacosanoate in Hemidesmus indicus R. Br. root powder by HPTLC. Journal of Planar Chromatography-Modern TLC. 2008; 22(6):453-6.
47.    Chatterjee I, Chakravarty AK, Gomes A. Daboia russellii and Naja kaouthia venom neutralization by lupeol acetate isolated from the root extract of Indian sarsaparilla Hemidesmus indicus R. Br. Journal of Ethnopharmacology. 2006; 106(1): 38-43.doi: 10.1016/j.jep.2005.11.031, PMID 16426782.
48.    Shreenithi S, Vishnupriya V, Ponnulakshmi R, Gayathri R, Madhan K, Shyamaladevi B, Selvaraj J. In silico and in vivo approach to identify the antidiabetic activity of lupeol. Drug Invention Today. 2019;11(5).
49.    Fernández MA, de las Heras B, Garcia MD, Sáenz MT, Villar A. New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. Journal of Pharmacy and Pharmacology. 2001;53(11):1533-9. doi: 10.1211/0022357011777909, PMID 11732756.
50.    Oliveira-Junior MS, Pereira EP, de Amorim VC, Reis LT, do Nascimento RP, da Silva VD, Costa SL. Lupeol inhibits LPS-induced neuroinflammation in cerebellar cultures and induces neuroprotection associated to the modulation of astrocyte response and expression of neurotrophic and inflammatory factors. International Immunopharmacology. 2019;70:302-12.doi: 10.1016/j.intimp.2019.02.055, PMID 30852286.
51.    Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414:813-20. doi: 10.1038/414813a, PMID 11742414.
52.    Cheng HM, González RG. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis. Metabolism. 1986;35(4):10-4. doi: 10.1016/0026-0495(86)90180-0, PMID 3083198.
53.    Petrash JM. All in the family: aldose reductase and closely related aldo-keto reductases. Cellular and Molecular Life Sciences CMLS. 2004; 61(7): 737-49.doi: 10.1007/s00018-003-3402-3, PMID 15094999.
54.    Jaspan J, Herold K, Maselli R, Bartkus C. Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function. The Lancet. 1983; 322(8353):758-62. doi:10.1016/S0140-6736(83)92296-1
55.    Ravishankara MN, Shrivastava N, Padh H, Rajani M. Evaluation of antioxidant properties of root bark of Hemidesmus indicus R. Br.(Anantmul). Phytomedicine. 2002; 9(2): 153-60. doi: 10.1078/0944-7113-00104, PMID 11995949.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available